← All trials
NCT01758159
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2013
- Primary completion
- Aug 31, 2013
- Completion date
- Apr 30, 2014
- First posted
- Jan 1, 2013
- Last posted
- Oct 1, 2013
- Enrollment
- 433
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- South East Asian Ministers of Education Organization, Regional Center for Food and Nutrition (SEAMEO-RECFON)Lead sponsor
- South East Asian Ministers of Education Organization, Regional Center for Food and Nutrition (SEAMEO-RECFON)Reponsible party - principal investigator
- South East Asian Ministers of Education Organization, Regional Center for Food and Nutrition (SEAMEO-RECFON)Sponsor investigator
- University of IndonesiaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.